Ajanta Pharma Ltd - Share Price
AJANTPHARM
Ajanta Pharma LtdFinancials
Ajanta Pharma LtdNews & Updates
Ajanta Pharma announces schedule of activities for proposed buyback
Nov 26,2020 12:46 PM
Ajanta Pharma announces schedule of activities for proposed buyback
Ajanta Pharma announces share buyback plan of Rs136cr; Q2 PAT records double-digit growth Nov 04,2020
Board of Ajanta Pharma recommends Interim Dividend Nov 04,2020
Ajanta Pharma gains after decent Q2 results, share buyback Nov 04,2020
Ajanta Pharma consolidated net profit rises 46.29% in the September 2020 quarter Nov 03,2020
Ajanta Pharma Q2 PAT rises 46% YoY; board approves buyback Nov 03,2020
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 582.90 | 48.53 | 139,845.24 | 724.81 | 0.69 | 3,207.24 | 106.10 |
| Divis Laboratories Ltd | 3,604.60 | 54.43 | 95,697.44 | 513.30 | 0.44 | 1,713.78 | 313.47 |
| Dr Reddys Laboratories Ltd | 5,052.20 | 34.22 | 84,024.72 | 481.00 | 0.49 | 3,333.60 | 979.38 |
| Cipla Ltd | 812.75 | 29.23 | 65,564.81 | 745.64 | 0.49 | 3,711.03 | 233.61 |
| Biocon Ltd | 441.95 | 155.62 | 53,034.00 | 95.00 | 0.00 | 560.00 | 64.73 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Ajanta Pharma LtdSummary & Reports
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. The company produces a comprehensive range of specialty products targeting different therapeutic segments. The companys business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. The branded... More
Registered Office
Ajanta House,Charkop Kandivli (W),Mumbai, Maharashtra,400067
Tell. : +91-22-66061000/1204/1203
Website : http://www.ajantapharma.com
Email : info@ajantapharma.com
Registrar Office
C-101 247 Park, Vikhroli West, Mumbai-400083 INDIA
Tell. : +91-22-49186000
Website : www.linkintime.com
Email : rnt.helpdesk@linkintime.co.in
Reports by ajanta-pharma-ltd-share-price
Latest Release by ajanta-pharma-ltd-share-price
Result Express
Jan 22, 2021 02:35 AM
The company’s consolidated revenue in the quarter stood at Rs485.11cr, down 17.36% yoy and 10.84% qoq.
Shareholding Snapshot
Loading ...
| Dec - 2020 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 70.34% |
| Total Promoter | 70.34% |
| Non Promoter | - |
| Institutions | 20.38% |
| Non-Institutions | 9.27% |
| Total Non-Promoter | 29.66% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Dividend
Annc. Date
03 Nov 2020
Effective. Date
12 Nov 2020
Divi. Type
Interim
Divi.(%)
475
Divi. Amt.
9.5
Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on... More
Purpose
Board Meeting
Exp. Date
03 Nov 2020
Annc. Date
23 Oct 2020
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sche... More
Purpose
AGM
Exp. Date
30 Jul 2020
Annc. Date
16 Jun 2020
a.The Forty-First (41st) Annual General Meeting (AGM) of the Company will be held on Thursday, 30th ... More
